S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
GILD   67.01 (-0.81%)
Log in

OTCMKTS:IRSB - Iris BioTechnologies Stock Price, Forecast & News

$0.04
0.00 (0.00 %)
(As of 08/20/2019)
Today's Range
$0.04
Now: $0.04
$0.04
50-Day Range
$0.04
MA: $0.04
$0.04
52-Week Range
$0.04
Now: $0.04
$0.41
VolumeN/A
Average Volume8,024 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Iris BioTechnologies, Inc., a life science company, develops solutions for the detection and monitoring of monogenic and complex genomic diseases. It is developing nano-biochip technology platform used for the diagnosis and treatment of patients with breast cancer, neurological disorders, heart diseases, diabetes, and other gene-related metabolic problems. The company also develops BioWindows, an artificial intelligence system, which provides data and analysis for clinical applications, drug development, and stem cell research. Iris BioTechnologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IRSB
Previous SymbolNASDAQ:IRSB
CUSIPN/A
Phone+1-408-8672885

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees7
Next Earnings DateN/A
OptionableNot Optionable

Receive IRSB News and Ratings via Email

Sign-up to receive the latest news and ratings for IRSB and its competitors with MarketBeat's FREE daily newsletter.


Iris BioTechnologies (OTCMKTS:IRSB) Frequently Asked Questions

What is Iris BioTechnologies' stock symbol?

Iris BioTechnologies trades on the OTCMKTS under the ticker symbol "IRSB."

How were Iris BioTechnologies' earnings last quarter?

Iris BioTechnologies Inc (OTCMKTS:IRSB) issued its quarterly earnings results on Tuesday, November, 15th. The company reported ($0.01) EPS for the quarter. View Iris BioTechnologies' Earnings History.

Has Iris BioTechnologies been receiving favorable news coverage?

News articles about IRSB stock have been trending extremely negative on Tuesday, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Iris BioTechnologies earned a news impact score of -5.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Iris BioTechnologies.

Who are some of Iris BioTechnologies' key competitors?

Who are Iris BioTechnologies' key executives?

Iris BioTechnologies' management team includes the folowing people:
  • Mr. Simon S. M. Chin MBA, Founder, Chairman, Chief Exec. Officer, Pres, Chief Financial Officer and Sec. (Age 60)
  • Mr. James LeBlanc MBA, VP of Operations (Age 72)
  • Dr. Paul Yaswen Ph.D., Chief Scientific Officer (Age 61)
  • Ms. Grace Osborne MBA, VP of Bus. Devel. & HR and Director (Age 52)
  • Dr. Ronald Mark Gemberling M.D., Chief Medical Officer (Age 72)

How do I buy shares of Iris BioTechnologies?

Shares of IRSB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Iris BioTechnologies' stock price today?

One share of IRSB stock can currently be purchased for approximately $0.04.

What is Iris BioTechnologies' official website?

The official website for Iris BioTechnologies is http://www.irisbiotech.com/.

How can I contact Iris BioTechnologies?

Iris BioTechnologies' mailing address is 5201 Great America Pkwy Ste 320, SANTA CLARA, CA 95054-1140, United States. The company can be reached via phone at +1-408-8672885.


MarketBeat Community Rating for Iris BioTechnologies (OTCMKTS IRSB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  65 (Vote Underperform)
Total Votes:  135
MarketBeat's community ratings are surveys of what our community members think about Iris BioTechnologies and other stocks. Vote "Outperform" if you believe IRSB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRSB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel